Named as a key player in 33 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Diabetic Retinopathy Drugs | Pharmaceuticals | $10.8 Bn | 6% |
Named as key players in the same markets as Roche Holding AG. (number of shared markets).
AbbVie Inc.1 shared market
Alimera Sciences1 shared market
Allergan (AbbVie Inc.)1 shared market
Ampio Pharmaceuticals.1 shared market
Bayer AG1 shared market
Genentech Inc.1 shared market
Novartis AG1 shared market
Regeneron Pharmaceuticals1 shared market